These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18673144)

  • 1. Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands.
    Weber KC; Honório KM; Andricopulo AD; Da Silva AB
    Med Chem; 2008 Jul; 4(4):328-35. PubMed ID: 18673144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.
    Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
    Eur J Pharm Sci; 2013 Feb; 48(3):532-41. PubMed ID: 23287365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.
    Heinrich T; Böttcher H; Gericke R; Bartoszyk GD; Anzali S; Seyfried CA; Greiner HE; Van Amsterdam C
    J Med Chem; 2004 Sep; 47(19):4684-92. PubMed ID: 15341484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
    J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chemometric study of the 5-HT(1A) receptor affinities presented by arylpiperazine compounds.
    Weber KC; da Silva AB
    Eur J Med Chem; 2008 Feb; 43(2):364-72. PubMed ID: 17562349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
    J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational methods in determination of pharmacophore models of 5-HT(1A), 5-HT(2A) and 5-HT(7) receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Jun; 13(7):933-51. PubMed ID: 23544602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.
    Honorio KM; Garratt RC; Andricopulo AD
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3119-25. PubMed ID: 15893927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship study of new potent and selective antagonists at the 5-HT(1A) and adrenergic alpha(1d) receptors: Derivatives of spiroethyl phenyl(substituted)piperazine.
    Sharma BK; Singh P; Sharma S
    J Enzyme Inhib Med Chem; 2006 Oct; 21(5):601-7. PubMed ID: 17194034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study on the affinity of some arylpiperazines towards the 5-HT1A/alpha1-adrenergic receptor using the E-state index.
    Debnath B; Samanta S; Naskar SK; Roy K; Jha T
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2837-42. PubMed ID: 14611840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT(1A)/5-HT(2A) receptor ligand with an anxiolytic-like activity.
    Bojarski AJ; Kowalski P; Kowalska T; Duszyńska B; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Bioorg Med Chem; 2002 Dec; 10(12):3817-27. PubMed ID: 12413835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of S-(-)-2-[[4-(napht-1-yl)piperazin-1-yl]methyl]-1,4-dioxoperhydropyrrolo[1,2-a]pyrazine (CSP-2503) using computational simulation. A 5-HT1A receptor agonist.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Olivella M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1429-32. PubMed ID: 12668005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.
    Weber KC; Salum LB; Honório KM; Andricopulo AD; da Silva AB
    Eur J Med Chem; 2010 Apr; 45(4):1508-14. PubMed ID: 20133028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators.
    Salum LB; Polikarpov I; Andricopulo AD
    SAR QSAR Environ Res; 2007; 18(7-8):711-27. PubMed ID: 18038369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.